X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (379) 379
index medicus (353) 353
humans (342) 342
female (233) 233
male (202) 202
adult (200) 200
middle aged (188) 188
aged (130) 130
cancer (112) 112
chemotherapy (83) 83
adolescent (80) 80
tumors (57) 57
sarcoma (49) 49
medicine & public health (47) 47
treatment outcome (46) 46
antineoplastic combined chemotherapy protocols - therapeutic use (45) 45
young adult (45) 45
child (43) 43
prognosis (42) 42
antineoplastic agents - therapeutic use (41) 41
aged, 80 and over (40) 40
care and treatment (39) 39
breast cancer (36) 36
metastasis (36) 36
research (36) 36
therapy (36) 36
breast-cancer (35) 35
neoplasms - drug therapy (35) 35
risk factors (35) 35
radiology, nuclear medicine & medical imaging (34) 34
retrospective studies (32) 32
surgery (32) 32
animals (31) 31
breast neoplasms - drug therapy (31) 31
abridged index medicus (29) 29
analysis (29) 29
antineoplastic combined chemotherapy protocols - adverse effects (29) 29
pharmacology & pharmacy (28) 28
diagnosis (26) 26
patients (25) 25
survival (25) 25
child, preschool (24) 24
disease-free survival (24) 24
expression (24) 24
health aspects (24) 24
medicine, general & internal (24) 24
surveys and questionnaires (24) 24
neoplasm staging (23) 23
p-glycoprotein (23) 23
quality of life (23) 23
hematology, oncology and palliative medicine (21) 21
sarcoma - drug therapy (21) 21
soft tissue sarcoma (21) 21
carcinoma (20) 20
immunohistochemistry (20) 20
mice (20) 20
neoplasms - psychology (20) 20
netherlands (20) 20
positron-emission-tomography (20) 20
prospective studies (20) 20
time factors (20) 20
pet (19) 19
antineoplastic agents - adverse effects (18) 18
chemotherapy, adjuvant (18) 18
doxorubicin (18) 18
drug therapy (18) 18
imatinib mesylate (18) 18
multidrug resistance (18) 18
breast neoplasms - pathology (17) 17
disease (17) 17
dose-response relationship, drug (17) 17
hematology (17) 17
neoplasm metastasis (17) 17
original (17) 17
psychology (17) 17
quality-of-life (17) 17
survivors (17) 17
trial (17) 17
antineoplastic combined chemotherapy protocols - administration & dosage (16) 16
breast neoplasms - therapy (16) 16
cisplatin (16) 16
drug resistance, multiple (16) 16
follow-up studies (16) 16
health care sciences & services (16) 16
imatinib (16) 16
palliative care (16) 16
protein kinase inhibitors - therapeutic use (16) 16
pyrimidines - therapeutic use (16) 16
radiotherapy (16) 16
sarcoma - pathology (16) 16
social sciences, biomedical (16) 16
soft-tissue sarcoma (16) 16
studies (16) 16
adolescents (15) 15
cancer patients (15) 15
combined modality therapy (15) 15
infection (15) 15
management (15) 15
monoclonal-antibody (15) 15
neoplasms - diagnosis (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 05/2009, Volume 50, pp. 43S - 54S
Molecular imaging with F-18-FDG PET has been proven useful in the management of colorectal cancer. F-18-FDG PET plays a pivotal role in staging before surgical... 
F-18-FDG PET | therapy monitoring | prediction | colorectal carcinoma | response monitoring | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
European Journal of Cancer, ISSN 0959-8049, 05/2018, Volume 95, pp. 20 - 29
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 10/2005, Volume 78, Issue 4, pp. 433 - 438
Interactions of imatinib with other drugs have been scarcely reported. We report a previously unknown effect of imatinib on levothyroxine therapy. Eleven... 
WOMEN | DRUG-THERAPY | HORMONE | THYROID-FUNCTION | L-THYROXINE | PHARMACOLOGY & PHARMACY | MALABSORPTION | ABSORPTION | LEUKEMIA
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9829, pp. 1879 - 1886
Journal Article
Lancet Oncology, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 415 - 423
Journal Article
NUCLEAR MEDICINE COMMUNICATIONS, ISSN 0143-3636, 05/2004, Volume 25, Issue 5, pp. 433 - 438
Background The new anti-cancer drug imatinib mesylate inhibits the tyrosine kinase growth factor receptor, c-KIT, and has shown spectacular activity in... 
POSITRON-EMISSION-TOMOGRAPHY | EFFICACY | SAFETY | TYROSINE KINASE | FDG | response evaluation | GISTS | KIT ACTIVATION | gastro-intestinal stroma tumours | INHIBITOR | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2018, Volume 36, Issue 16, pp. 1642 - 1643
Journal Article